ReposiTrak (TRAK)
NYSE:TRAK
Want to see TRAK full AI Analyst Report?
Earnings Data
Report Date
Oct 05, 2026After Close (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
0.09Last Year’s EPS
0.09Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized strong margin expansion, balance sheet strength (zero bank debt, ~$26.4M cash), high-quality recurring revenue (now >98%), active capital return programs, patent filings, and early commercial wins for touchless traceability. Key challenges include a flat Q3 revenue due to timing shifts from FDA deadline extensions, a significant increase in tax expense as NOL benefits expire, substantial supplier data quality issues that require AI remediation, and longer sales cycles for traceability with some uncertainty around the Spar Group partnership's near-term revenue impact. Overall, the positives—notably profitability, cash generation, recurring revenue conversion, IP, and shareholder returns—outweigh the near-term timing and execution risks.Company Guidance
High Proportion of Recurring Revenue
Recurring revenue increased from ~62% of total revenue in fiscal 2020 to more than 98% today; converted more than $7.0M of former one-time revenue into recurring SaaS streams since fiscal 2020, improving predictability and revenue quality.
Strong Profitability and Margin Expansion
Net margins expanded from approximately 8% several years ago to north of 30% today; Q3 operating income rose 24% YoY to ~$2.3M; year-to-date operating income increased 28% to $6.0M.
Cost Discipline and Expense Reductions
Total operating expenses decreased 12% YoY in Q3 to $3.6M (from $4.1M) and declined 4% YTD to $11.7M; operating expense run-rate reduced from roughly $19M in fiscal 2020 to ~$16M.
Strong Balance Sheet and Cash Generation
Ended the quarter with ~$26.4M in cash and zero bank debt; net cash (cash less bank debt and lease obligations) compounded at ~16% annually since fiscal 2020 and grew from ~$13.7M (FY2020) to nearly $28M by fiscal 2025; operating cash flow of $6.0M for the first 9 months of fiscal 2026.
Shareholder Returns and Capital Allocation
Returned roughly $5.0M to shareholders year-to-date via buybacks, preferred redemptions, and dividends; repurchased 144k common shares in fiscal 2026 for ~$1.8M (avg ~$12.50) and 2.3M shares since program inception for ~$15.0M (avg ~$6.60), with $6.0M remaining under authorization; declared quarterly dividend of $0.02 (3rd consecutive annual 10% increase).
Revenue and EPS Progress Year-to-Date
Total revenue increased 5% YTD to $17.7M (from $16.8M); GAAP net income increased 6% YTD to $5.5M and net income attributable to common shareholders increased 9% to $5.4M; YTD diluted EPS rose 9% to $0.28.
Product Innovation and IP Expansion
Filed 2 additional patent applications during the quarter (including one for touchless traceability), bringing the U.S. patent portfolio to 9 patents; advancing touchless traceability, AI-based data integrity correction, and modernization of software architecture with targeted AI initiatives.
Commercial Validation of Touchless Traceability and Strategic Partnership
Announced full end-to-end touchless traceability deployments with a leading grocery retailer and a leading wholesale grocery cooperative in the Southern U.S.; formed a collaboration with Spar Group to convert diagnostic insights into in-store remediation services, with management expecting financial impact within ~6–9 months and early high-potential prospect engagement with a major CPG.
TRAK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TRAK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | $9.10 | $9.70 | +6.59% |
Feb 17, 2026 | $10.06 | $9.18 | -8.82% |
Nov 13, 2025 | $14.94 | $14.97 | +0.27% |
Sep 29, 2025 | $16.47 | $14.76 | -10.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does ReposiTrak (TRAK) report earnings?
ReposiTrak (TRAK) is schdueled to report earning on Oct 05, 2026, After Close (Confirmed).
What is ReposiTrak (TRAK) earnings time?
ReposiTrak (TRAK) earnings time is at Oct 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TRAK EPS forecast?
TRAK EPS forecast for the fiscal quarter 2026 (Q4) is 0.09.